Topic
Pharmaceutical Industry
85 published works
Duane Morris Vietnam
ANWALT IN VIETNAM DR. OLIVER MASSMANN – AUSLÄNDISCHE PHARMAUNTERNEHMEN – IMPORT UND DISTRIBUTION – WAS SIE WISSEN MÜSSEN
Der vietnamesische Pharmamarkt gehört zu den am schnellsten wachsenden in Asien. Mit einer Bevölkerung von über 100 Millionen, steigenden Gesundheitsausgaben, einer wachsenden Mittelschicht und einem zunehmend anspruchsvollen regulatorischen Rahmen bietet…
BioSlice Blog
A New 2024 Code for the British Pharmaceutical Industry – “The Future is Orange”
By Adela Williams, Libby Amos-Stone, Katya Farkas
On 23 September 2024, the Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) published an updated Code of Practice for the pharmaceutical…
Health Law Prof Blog
Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation
Laura Karas (Harvard Law School), Robin Feldman (UC San Francisco), Ge Bai (Johns Hopkins University), So-Yeon Kang (Johns Hopkins University), et al., Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National…
Cleary Antitrust Watch
Commission Gets Active Again In The Pharmaceutical Sector: First-Ever Cartel Decision In Relation To An Active Pharmaceutical Ingredient
By Liam Rowley, Kristi Georgieva, Julia Blanco
On October 19, 2023, the Commission imposed fines totalling €13.4 million on five pharmaceutical companies (Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, and Transo-Pharm) for their participation in a cartel…
China Law Update Blog
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmaceutical Industry in China
By Michael Zhang, Minjie Lu*, Zhenye Wang, Jiaqi Shao*
On May 8, 2023, the National Health Commission of the People’s Republic of China (the “PRC”), along with 13 other government departments of the PRC, issued the "Key Highlights for…
Health Law Prof Blog
Corporate Crimes in the Medical and Pharmaceutical Industry
Swanith Kapoor (UPES), Corporate Crimes in the Medical and Pharmaceutical Industry (2023): A corporate crime refers to a crime that is committed either by a corporation or by an individual or…
China Law Insight
中国医药行业投资新机遇
By King & Wood
作者：黄建雯 张宇 梁晓言 本文为黄建雯律师受《法律500强》邀请作为中国医疗与生命科学领域Focus On专栏独家作者撰写。 我国医药行业近年来不断出台各类鼓励政策，优化外商投资环境，在市场和政策的双重激励下，我国医药行业得到快速发展。2022年中国区医药交易活跃度居于世界前列，交易总金额达到346亿美元，同比增长10%。 本文梳理了我国医药行业近年来值得关注的新规新政，并将主要围绕如下五点展开介绍：（1）中国药品、医疗器械监管制度改革；（2）《鼓励外商投资产业目录》增加医药产业条目；（3）药品网络销售新规出台；（4）互联网医院监管政策落地实施；以及（5）允许港澳MAH跨境委托生产。 阅读更多
The Healthcare Investor
Strong Margins and Recession Resistant: The Allure of Pharma Services
The pharmaceutical services industry has piqued the interest of private equity investors over the last five to 10 years as more drugs move into development and high-quality science continues to…
Inside EU Life Sciences
EU Talking Life Sciences Audiocast: Episode 1 – Key Developments in the Pharma Sector: A Review of 2022 and Insights for 2023
By Grant Castle, Peter Bogaert, Marie Doyle-Rossi
Tune into the first episode of Covington's Talking Life Sciences Audiocast, where Grant Castle, Peter Bogaert and Marie Doyle-Rossi discuss key developments and trends in the pharma sector. Our speakers…
The Right Coast
Private-sector research could pose a pandemic risk. Here’s what to do about it – Bulletin of the Atomic Scientists
In 2018, Canadian academics with pharmaceutical industry funding made a stunning announcement. They had synthesized horsepox, a pathogen that no longer exists in nature and that is closely related to…